Work

Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review

Year: 2019

Type: erratum

Source: PharmacoEconomics

DOI: 10.1007/s40273-019-00833-1

Authors: Dongzhe Hong, Lei Si, Minghuan Jiang, Hui Shao, Wai-kit Ming, Yingnan Zhao, Yan Li, Lizheng Shi

Institutions: Tulane University, UNSW Sydney, The George Institute for Global Health, Xi'an Jiaotong University, Harvard University, The First Affiliated Hospital, Sun Yat-sen University, Xavier University of Louisiana, New York Academy of Medicine, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4236091789

Cites: 1

Cited by: 28

Related to: 10